Literature DB >> 3733298

Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteers.

J A Caetano, M T Paramés, M J Babo, A Santos, A B Ferreira, A A Freitas, M R Coelho, A M Mateus.   

Abstract

Investigation of oral administration of Saccharomyces boulardii in healthy volunteers demonstrates several cellular and humoral changes in peripheral blood. Among its effects are the increase of erythrocytes, leucocytes, polymorphs, neutrophils, complement components C3, C5, C3d, serum anticomplementary activity and leucocyte chemokinesis, specially when autologous serum and antigen have been added to the culture medium and decrease of complement haemolytic activity (CH50, classic and alternative pathways). We have also demonstrated that in vitro S. boulardii was able to activate complement directly, to fix C3b to its surface and that its phagocytosis by mononuclear cells was complement-dependent. The overall changes in serum proteins suggested changes of acute phase proteins typical of an inflammatory process. Furthermore S. boulardii had no mitogenic response of lymphocyte populations. Our results demonstrated that S. boulardii activates the reticuloendothelial system and complement system and suggest that S. boulardii merits therapeutic trial in a variety of clinical situations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733298     DOI: 10.1016/0192-0561(86)90106-2

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  6 in total

Review 1.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii.

Authors:  J P Buts; P Bernasconi; J P Vaerman; C Dive
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

3.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

Review 4.  Beneficial effects of probiotic and food borne yeasts on human health.

Authors:  Saloomeh Moslehi-Jenabian; Line Lindegaard Pedersen; Lene Jespersen
Journal:  Nutrients       Date:  2010-04-01       Impact factor: 5.717

5.  Probiotics for vaginal health in South Africa: what is on retailers' shelves?

Authors:  Anna-Ursula Happel; Shameem Z Jaumdally; Tanya Pidwell; Tracy Cornelius; Heather B Jaspan; Remy Froissart; Shaun L Barnabas; Jo-Ann S Passmore
Journal:  BMC Womens Health       Date:  2017-01-19       Impact factor: 2.809

Review 6.  Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system.

Authors:  Heike Stier; Stephan C Bischoff
Journal:  Clin Exp Gastroenterol       Date:  2016-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.